Verification and Validation of a Four-Gene Panel as a Prognostic Indicator in Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is a highly aggressive subtype with a high rate of metastasis, early distant recurrence and resistance to therapy leading to worse survival than other breast cancer subtypes. There are no well-established biomarkers that can determine women who will do better and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariyar, Mamta, Thorne, Rick F., Scott, Rodney J., Avery-Kiejda, Kelly A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977600/
https://www.ncbi.nlm.nih.gov/pubmed/35387118
http://dx.doi.org/10.3389/fonc.2022.821334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977600/
https://www.ncbi.nlm.nih.gov/pubmed/35387118
http://dx.doi.org/10.3389/fonc.2022.821334

Ejemplares similares